- Home
- PETS vs TTOO Comparison
PETS vs TTOO Comparison
Compare PETS & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETS
- TTOO
- Stock Information
- Founded
- PETS 1996
- TTOO 2006
- Country
- PETS United States
- TTOO United States
- Employees
- PETS N/A
- TTOO N/A
- Industry
- PETS Retail-Drug Stores and Proprietary Stores
- TTOO Medical/Dental Instruments
- Sector
- PETS Consumer Staples
- TTOO Health Care
- Exchange
- PETS Nasdaq
- TTOO Nasdaq
- Market Cap
- PETS 82.0M
- TTOO 36.4M
- IPO Year
- PETS N/A
- TTOO 2014
- Fundamental
- Price
- PETS $4.07
- TTOO $0.97
- Analyst Decision
- PETS Sell
- TTOO Hold
- Analyst Count
- PETS 2
- TTOO 1
- Target Price
- PETS $3.50
- TTOO $5.00
- AVG Volume (30 Days)
- PETS 182.6K
- TTOO 710.5K
- Earning Date
- PETS 11-06-2024
- TTOO 11-13-2024
- Dividend Yield
- PETS 29.41%
- TTOO N/A
- EPS Growth
- PETS N/A
- TTOO N/A
- EPS
- PETS N/A
- TTOO N/A
- Revenue
- PETS $270,772,000.00
- TTOO $7,164,000.00
- Revenue This Year
- PETS N/A
- TTOO $50.31
- Revenue Next Year
- PETS $3.27
- TTOO $117.92
- P/E Ratio
- PETS N/A
- TTOO N/A
- Revenue Growth
- PETS 2.26
- TTOO N/A
- 52 Week Low
- PETS $2.90
- TTOO $0.90
- 52 Week High
- PETS $8.27
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- PETS 56.76
- TTOO 18.34
- Support Level
- PETS $3.78
- TTOO $0.90
- Resistance Level
- PETS $4.17
- TTOO $1.86
- Average True Range (ATR)
- PETS 0.18
- TTOO 0.15
- MACD
- PETS -0.01
- TTOO -0.00
- Stochastic Oscillator
- PETS 62.22
- TTOO 5.72
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.